PharmaCyte Biotech Inc (PMCB) Unusual Options Activity Today

Checking PMCB unusual options activity helps you spot when traders are making outsized bets on PharmaCyte Biotech Inc before the broader market catches on. PharmaCyte Biotech Inc's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor PMCB unusual options activity today and surface the prints that deserve a second look.

Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching PMCB unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking PMCB unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and PMCB unusual options flow data becomes especially valuable around earnings, product launches, and macro events.

PharmaCyte Biotech, Inc., a biotechnology company, focuses on developing and commercializing cellular therapies for cancer, diabetes, and malignant ascites in the United States. Its cellular therapies are developed based on Cell-in-a-Box, a proprietary cellulose-based live cell encapsulation technology used as a platform to treat various types of cancer, including advanced and inoperable pancreatic cancer, as well as diabetes. The company is developing therapies for pancreatic and other solid cancerous tumors; a therapy for Type 1 diabetes and insulin-dependent Type 2 diabetes, which include encapsulated genetically modified insulin-producing cells; and therapies for cancer based on the constituents of the cannabis plant.

It has a research agreement with the University of Technology, Sydney to create a version of melligen cells to treat diabetes; and the University of Northern Colorado to develop methods for the identification, separation, and quantification of constituents of cannabis. The company was formerly known as Nuvilex, Inc. and changed its name to PharmaCyte Biotech, Inc. in January 2015. PharmaCyte Biotech, Inc. was incorporated in 1996 and is headquartered in Las Vegas, Nevada.

Catalysts rarely arrive without a footprint, and PMCB unusual options activity is often where that footprint shows up first. Our scanner tracks PharmaCyte Biotech Inc's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at PMCB unusual options volume on the call side or chasing put sweeps, PharmaCyte Biotech Inc's unusual options flow today is one click away, so put it on your radar before the headlines hit.